glp-1 and bipolar GLP-1s: Real Stories From People With Disorder Understand GLP-1/GIP Dual Agonist Tirzepatide

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Ryan KK et al

As the demand for innovative, effective treatments for diabetes and obesity continues to rise, the GLP-1 market is expected to expand further, with new drug approvals and improved treatment options likely to drive continued success

Lawrence Afrin and colleagues presented the first comprehensive case series documenting the utility of GLP-1 receptor agonists in managing mast cell activation syndrome

Vestibular Disorders

Other medications commonly prescribed alongside Rybelsus, such as SGLT2 inhibitors, can increase glucose in the urine and raise the risk of UTIs, potentially contributing to urine odour changes independently

Studies consistently show that individuals with obesity have higher rates of alcohol use disorder, and vice versa